“Interleukin-1 (IL-1) inhibitors can be considered for treatment of gout flare in patients who have inadequate response to or are contraindicated for standard treatment (including colchicine, NSAIDs, and/or glucocorticoids). The gene discussed is IL1B; the disease is gout.